Neutrolin is a liquid that locks a patient’s central venous catheter (CVC) between hemodialysis (HD) sessions to keep it free of infection and clots.
Bruce Cooper, president and CEO of CorMedix, said: “We hope Neutrolin will be a paradigm-changing weapon in fighting one of the single greatest causes of morbidity and mortality among the 300,000 kidney failure patients in the US who undergo life-sustaining HD treatments.”